Science firm linked to Duke professor raises $27M for stroke treatment

A drug company with ties to Duke University has raised fresh capital as it develops a treatment for strokes.

Previous Business First opens nominations for inaugural health care awards
Next Big Ice, largest specialty cocktail ice maker in the Midwest, makes acquisition, expands footprint